Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to $72.0 million.

  • Angiodynamics' Total Current Liabilities fell 1877.31% to $72.0 million in Q4 2025 from the same period last year, while for Nov 2025 it was $72.0 million, marking a year-over-year decrease of 1877.31%. This contributed to the annual value of $76.2 million for FY2025, which is 1640.94% down from last year.
  • Angiodynamics' Total Current Liabilities amounted to $72.0 million in Q4 2025, which was down 1877.31% from $68.3 million recorded in Q3 2025.
  • In the past 5 years, Angiodynamics' Total Current Liabilities ranged from a high of $91.2 million in Q2 2024 and a low of $49.4 million during Q1 2022
  • Over the past 5 years, Angiodynamics' median Total Current Liabilities value was $72.8 million (recorded in 2022), while the average stood at $70.2 million.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first skyrocketed by 4104.68% in 2023, then tumbled by 1877.31% in 2025.
  • Over the past 5 years, Angiodynamics' Total Current Liabilities (Quarter) stood at $54.5 million in 2021, then soared by 35.05% to $73.6 million in 2022, then grew by 6.08% to $78.0 million in 2023, then increased by 13.53% to $88.6 million in 2024, then decreased by 18.77% to $72.0 million in 2025.
  • Its last three reported values are $72.0 million in Q4 2025, $68.3 million for Q3 2025, and $76.2 million during Q2 2025.